V-Square Quantitative Management’s Charles River Laboratories CRL Stock Holding History

V-Square Quantitative Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$354K	Buy	1,561 +71	+5%	+$12.6K	0.03%	412
2026 Q1	$257K	Sell	1,490 -68	-4%	-$12.6K	0.03%	486
2025 Q4	$311K	Buy	+1,558	New	+$283K	0.03%	422
2025 Q3	–	Sell	-1,780	Closed	-$270K	–	250
2025 Q2	$270K	Buy	1,780 +594	+50%	+$79.2K	0.04%	445
2025 Q1	$179K	Buy	1,186 +102	+9%	+$17.1K	0.03%	518
2024 Q4	$200K	Buy	1,084 +121	+13%	+$23.3K	0.03%	507
2024 Q3	$190K	Buy	963 +39	+4%	+$8.11K	0.03%	517
2024 Q2	$191K	Sell	924 -38	-4%	-$8.61K	0.03%	507
2024 Q1	$261K	Hold	962	–	–	0.04%	407
2023 Q4	$227K	Hold	962	–	–	0.04%	388
2023 Q3	$189K	Buy	+962	New	+$198K	0.08%	383

Other funds holding CRL

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

LKIM

Lawson Kroeker Investment Management Omaha, Nebraska $361M AUM 22.26% 1-Year Est. Return

V-Square Quantitative Management's CRL Position: Q2 2026 in Review

V-Square Quantitative Management increased its Charles River Laboratories (CRL) stake by 4.8% in Q2 2026, buying an estimated $12.6K and bringing the position to 1,561 shares worth $354K. The position accounts for 0.03% of the portfolio, ranked #412.

V-Square Quantitative Management first reported a position in CRL in Q3 2023 and has held it in 11 quarters since. 158 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

V-Square Quantitative Management held 1,561 shares of Charles River Laboratories worth $354K as of Q2 2026.
V-Square Quantitative Management bought 71 Charles River Laboratories shares in Q2 2026, an estimated $12.6K.
Charles River Laboratories made up 0.03% of V-Square Quantitative Management's portfolio in Q2 2026, its #412 holding.
V-Square Quantitative Management first reported a position in Charles River Laboratories in Q3 2023 and has held it in 11 quarters since.
158 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.